PARTICIPATION OF KAMRON AT I-PHEX 2016 EXHIBITION 01-01-2016 We are participating in IPHEX AFRICA at Lagos, Nigeria on 18th and 19th Fabruary. Visit us at Stall No. 315 Celebrating this year a Silver Jubilee Year 01-07-2014 By celebrating this 25th year of Kamron Laboratories we are celebrating the success of the courage, aspiration, enthusiasm, energy and hard work of every one who belongs to the Kamron. PICTURES OF THE CELEBRATION ALL OVER INDIA :- Participation of Kamron in I-Phex 2014 exhibition MAY 2014 01-05-2014 Kamron participated in the 1st edition of I-PHEX 2013 Exhibition which was organised by PHARMEXCIL (Pharmaceutical Export Promotion Council of India) at Bombay Exhibition Centre, Mumbai from 24th – 26th April 2013. In this exhibition more than 500 overseas buyers had participated. Our representatives got a chance to interact with many buyers and we have tied-up with several buyers for marketing of our pharmaceutical products in their respective countries. Steps have been taken to get the plant/ products approved in many countries. Some approvals have come and we are expecting many more approvals. In line with our vision of developing exports of our products and enhance our global footprint we will be participating in the 2nd edition of I-Phex 2014 to be held at Bombay Exhibition Centre, Mumbai from 21st – 23rd May 2014. We are pleased to invite you to visit us at our Stall B 11 during these dates. Kamron succesfully develops Sublingual and Chewable Tablets Manufacturing Technology. 01-04-2014 Research and Development is at the centre of all activities done at Kamron. Our Formulations R&D Department has successfully developed manufacturing technology to produce Sublingual and Chewable Tablets. We now offer Sildnenafil Tablets and Tadanafil Tablets in Chewable as well as Sublingual dosage forms. Kamron gets renewal of its WHO-GMP Certification till February 2016 01-02-2014 Kamron is proud to share with all its stakeholders that it has successfully been able to get the renewal of its WHO-GMP Certification which shows that at Kamron the topmost priority is given to manufacture world class medicines. There are continuous revisions done in the norms of the World Health Organisation—Good Manufacturing Practices and to comply with these norms periodical upgradations are required in the manufacturing facilities.This certificate is accepted by a majority of countries as a symbol of good quality and is a prerequisite for exporting medicines out of India. Kamron’s WHO-GMP Certificate is now valid upto February 2016.